A 17-year-old Aboriginal woman from a remote Northern Territory community has known rheumatic heart disease with moderate mitral regurgitation following definite acute rheumatic fever at age 13. She is otherwise well and is not pregnant. There is concern that she sometimes misses her injections. According to Australian ARF/RHD guidelines, which secondary prophylaxis regimen is most appropriate?